Boiron SA
PAR:BOI

Watchlist Manager
Boiron SA Logo
Boiron SA
PAR:BOI
Watchlist
Price: 28.1 EUR -4.75% Market Closed
Market Cap: 487.9m EUR
Have any thoughts about
Boiron SA?
Write Note

Relative Value

The Relative Value of one BOI stock under the Base Case scenario is 43.43 EUR. Compared to the current market price of 28.1 EUR, Boiron SA is Undervalued by 35%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BOI Relative Value
Base Case
43.43 EUR
Undervaluation 35%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
68
vs Industry
67
Median 3Y
1.4
Median 5Y
1.3
Industry
2.5
Forward
1
vs History
12
vs Industry
28
Median 3Y
17.3
Median 5Y
16
Industry
21.9
Forward
12.8
vs History
39
vs Industry
31
Median 3Y
13.6
Median 5Y
12.2
Industry
16.5
vs History
44
vs Industry
18
Median 3Y
31.2
Median 5Y
28.8
Industry
23.6
vs History
17
vs Industry
50
Median 3Y
1.5
Median 5Y
1.3
Industry
2.1
vs History
26
vs Industry
72
Median 3Y
1.1
Median 5Y
0.9
Industry
2.6
Forward
0.9
vs History
30
vs Industry
78
Median 3Y
1.5
Median 5Y
1.3
Industry
5.2
vs History
3
vs Industry
40
Median 3Y
7.4
Median 5Y
6
Industry
13.3
Forward
6.2
vs History
11
vs Industry
35
Median 3Y
10.2
Median 5Y
8.9
Industry
16.6
Forward
10
vs History
31
vs Industry
36
Median 3Y
11.9
Median 5Y
8.3
Industry
15.6
vs History
42
vs Industry
21
Median 3Y
20.8
Median 5Y
19.6
Industry
19.1
vs History
25
vs Industry
55
Median 3Y
1.1
Median 5Y
1
Industry
1.9

Multiples Across Competitors

BOI Competitors Multiples
Boiron SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Boiron SA
PAR:BOI
487.9m EUR 1 20.6 8.2 14.9
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
FR
Boiron SA
PAR:BOI
Average P/E: 30.9
20.6
12%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top